WBA (Walgreens Boots Alliance NASDAQ) $11.98 AH 13 Mar 2026: Most active view

WBA stock is trading after hours at $11.98 on 13 Mar 2026 on the NASDAQ in the United States, making it one of the most active names by volume tonight. The move follows heavy volume of 452081061.00 shares and a market cap near 10.37B USD, signaling strong investor attention. Key metrics driving the session include a trailing EPS of -7.29, a PE of -1.64, and year range between 8.08 and 13.25. Below we break down price action, recent financials, Meyka AI grade, technical liquidity, and an explicit forecast for traders and long-term investors.

WBA stock price action and session snapshot

WBA (Walgreens Boots Alliance, Inc.) closed the regular session at $11.92 and is $11.98 after hours on 13 Mar 2026, up 0.06 USD or 0.50% intraday. Volume today hit 452081061.00 versus an average volume of 16940296.00, giving a relative volume of 26.69 and marking it as a most active ticker in the after hours market. Market capitalization stands at 10369421068.00 USD, with 865561024.00 shares outstanding. These figures show heightened trading interest despite muted intraday price range of 11.98 to 11.98.

WBA stock financials and earnings context

Walgreens Boots Alliance reports a trailing EPS of -7.29 and a negative net income per share of -3.81, reflecting recent operational pressure. Revenue per share is 135.31, while book value per share is 8.46. Key ratios show price to sales of 0.09, price to book of 1.44, and debt to equity near 4.04, underlining a capital structure with high leverage. The next earnings announcement is scheduled for 25 Jun 2025, and recent growth metrics show revenue up 6.17% year over year but operating cash flow contraction of 54.92% compared to the prior period.

Analyst view and Meyka AI rates WBA with a score out of 100

Meyka AI rates WBA with a score out of 100: 59.51 / 100, Grade C+, Suggestion: HOLD. This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, analyst consensus, and forecasts. The platform’s consensus tilt is mixed: the upgrade/downgrade snapshot shows a sole sell rating on record and a consensus score of 2.00. We emphasize this grade is informational only and not financial advice. Analysts point to retail footprint strength but flag earnings volatility and leverage as primary concerns.

Technicals, liquidity and trading metrics for WBA stock

Technically, momentum indicators are stretched with an RSI at 100.00, and ADX at 50.00 signaling a strong trend in volume terms. The 50-day average price is 11.66 and the 200-day average is 10.81, indicating a short-term uptrend versus longer-term price action. On-balance volume reads 452081061.00, reflecting today’s heavy flows. Liquidity is high after hours but the current ratio is 0.60, and interest coverage is negative at -5.67, which increases balance sheet sensitivity to rate moves and investor sentiment.

WBA stock risks and opportunities

Major risks include high leverage with debt to equity at 4.04, negative free cash flow per share of -0.59, and weak profitability metrics such as ROE of -38.80%. Opportunities include a large retail footprint, pharmacy margin potential, and a recovering YTD gain of 30.36% which shows investor rotation back into the name. Valuation metrics like price to sales at 0.09 could appeal to value-seeking investors if operating metrics stabilize. Market and sector performance in Healthcare will remain a near-term driver.

WBA stock outlook and Meyka AI forecast

Meyka AI’s forecast model projects a yearly figure of 4.08 USD, which when compared with the current price of 11.98 USD implies an approximate downside of -65.94%. This projection is model-based and assumes stressed operating margins and capital structure effects; forecasts are not guarantees. For scenario planning, analysts publish price targets ranging widely; our technical and fundamental review suggests monitoring earnings on 25 Jun 2025 and leverage remediation before adding material long exposure.

Final Thoughts

WBA stock is one of the most active after hours tickers on 13 Mar 2026, trading at 11.98 USD on the NASDAQ in the United States amid unusually high volume of 452081061.00 shares. Our analysis highlights a mixed setup: strong retail scale and improving short-term price momentum versus high leverage, negative EPS of -7.29, and thin free cash flow. Meyka AI’s model projects 4.08 USD, implying a potential downside near -65.94% versus the current price, and the proprietary grade sits at 59.51 (C+, HOLD). Investors should treat this as a data-driven scenario, not investment advice, and watch the upcoming earnings report on 25 Jun 2025 and any debt reduction updates. For active traders, the stretched RSI and heavy volume offer short-term trading opportunities; long-term investors should wait for clearer signs of cash flow recovery and deleveraging. For live streaming data and alerts, see WBA on Meyka AI and follow primary news sources for earnings and sector shifts.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.